美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=EMTRICITABINE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
EMTRICITABINE 090488 001 ANDA EMTRICITABINE CAPSULE; ORAL 200MG No 2008/12/23 (TA) MATRIX LABS LTD None (Tentative Approval)
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 090049 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG; 300MG No 2009/03/30 (TA) MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 090437 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG; 200MG; 300MG No 2009/08/12 (TA) MATRIX LABS LTD None (Tentative Approval)
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 201806 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG; 300MG No 2011/12/22 (TA) HETERO LABS UNIT III None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 002 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 003 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091055 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG; 300MG No 2013/07/31 (TA) STRIDES ARCOLAB LTD None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 203053 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG; 200MG; 300MG No 2013/10/31 (TA) HETERO LABS LTD V None (Tentative Approval)
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 090958 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG; 300MG No 2014/02/26 (TA) CIPLA LTD None (Tentative Approval)
EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE 206042 001 NDA EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE TABLET;ORAL 200MG;300MG;200MG No 2014/09/12 (TA) MYLAN LABS LTD None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 204287 001 ANDA EFAVIRENZ;EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 600MG;200MG;300MG No 2014/11/28 (TA) MACLEODS PHARMS LTD None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 090894 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 200MG;300MG No No 2017/06/08 2017/06/08 TEVA PHARMS USA Prescription
EMTRICITABINE;RILPIVIRINE;TENOFOVIR DISOPROXIL FUMARATE 208452 001 ANDA EMTRICITABINE;RILPIVIRINE;TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 200MG;25MG;300MG No 2017/11/20 (TA) MYLAN PHARMS INC None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 090513 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 200MG;300MG No No 2018/01/26 2018/01/26 AUROBINDO PHARMA LTD Prescription
EMTRICITABINE 079188 001 ANDA EMTRICITABINE CAPSULE; ORAL 200MG No 2018/03/23 (TA) AUROBINDO PHARMA None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 206436 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 200MG;300MG No No 2018/04/09 2018/04/09 MYLAN Prescription
EMTRICITABINE 091168 001 ANDA EMTRICITABINE CAPSULE;ORAL 200MG No No 2018/07/02 2018/07/02 CIPLA Prescription
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 209721 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 100MG;150MG No No 2018/08/22 2018/08/22 AMNEAL PHARMS CO Discontinued
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 209721 002 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 133MG;200MG No No 2018/08/22 2018/08/22 AMNEAL PHARMS CO Discontinued
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database